These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22503729)

  • 1. Mutation analysis of LRRK2, SCNA, UCHL1, HtrA2 and GIGYF2 genes in Chinese patients with autosomal dorminant Parkinson's disease.
    Tian JY; Guo JF; Wang L; Sun QY; Yao LY; Luo LZ; Shi CH; Hu YC; Yan XX; Tang BS
    Neurosci Lett; 2012 May; 516(2):207-11. PubMed ID: 22503729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
    Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
    Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.
    Xiromerisiou G; Hadjigeorgiou GM; Gourbali V; Johnson J; Papakonstantinou I; Papadimitriou A; Singleton AB
    Eur J Neurol; 2007 Jan; 14(1):7-11. PubMed ID: 17222106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease.
    Seki N; Takahashi Y; Tomiyama H; Rogaeva E; Murayama S; Mizuno Y; Hattori N; Marras C; Lang AE; George-Hyslop PS; Goto J; Tsuji S
    J Hum Genet; 2011 Sep; 56(9):671-5. PubMed ID: 21796139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease.
    Lesage S; Condroyer C; Lannuzel A; Lohmann E; Troiano A; Tison F; Damier P; Thobois S; Ouvrard-Hernandez AM; Rivaud-Péchoux S; Brefel-Courbon C; Destée A; Tranchant C; Romana M; Leclere L; Dürr A; Brice A;
    J Med Genet; 2009 Jul; 46(7):458-64. PubMed ID: 19357115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.
    Saini P; Rudakou U; Yu E; Ruskey JA; Asayesh F; Laurent SB; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Espay AJ; Rouleau GA; Alcalay RN; Fon EA; Postuma RB; Gan-Or Z
    Neurobiol Aging; 2021 Apr; 100():119.e7-119.e13. PubMed ID: 33239198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of rare variants of autosomal-dominant genes in a Chinese population with sporadic Parkinson's disease.
    Zheng R; Jin CY; Chen Y; Ruan Y; Gao T; Lin ZH; Dong JX; Yan YP; Tian J; Pu JL; Zhang BR
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1449. PubMed ID: 32794657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.
    Pchelina SN; Yakimovskii AF; Emelyanov AK; Ivanova ON; Schwarzman AL; Singleton AB
    Eur J Neurol; 2008 Jul; 15(7):692-6. PubMed ID: 18435766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease.
    Wang CY; Xu Q; Weng L; Zhang Q; Zhang HN; Guo JF; Tan LM; Tang JG; Yan XX; Tang BS
    Brain Res; 2011 Apr; 1385():293-7. PubMed ID: 21338583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.
    Di Fonzo A; Tassorelli C; De Mari M; Chien HF; Ferreira J; Rohé CF; Riboldazzi G; Antonini A; Albani G; Mauro A; Marconi R; Abbruzzese G; Lopiano L; Fincati E; Guidi M; Marini P; Stocchi F; Onofrj M; Toni V; Tinazzi M; Fabbrini G; Lamberti P; Vanacore N; Meco G; Leitner P; Uitti RJ; Wszolek ZK; Gasser T; Simons EJ; Breedveld GJ; Goldwurm S; Pezzoli G; Sampaio C; Barbosa E; Martignoni E; Oostra BA; Bonifati V;
    Eur J Hum Genet; 2006 Mar; 14(3):322-31. PubMed ID: 16333314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.
    Lin CH; Chen ML; Chen GS; Tai CH; Wu RM
    Hum Genet; 2011 Dec; 130(6):817-27. PubMed ID: 21701785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LRRK2 gene is mutated in a Chinese autosomal-dominant Parkinson's disease family.
    Guo R; Hu X; Chen Q; Zhang Y; Zhang Y; Sun Y; Hu G
    Genet Test Mol Biomarkers; 2013 Feb; 17(2):131-4. PubMed ID: 23268655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China.
    Fu X; Zheng Y; Hong H; He Y; Zhou S; Guo C; Liu Y; Xian W; Zeng J; Li J; Liu Z; Chen L; Pei Z
    Parkinsonism Relat Disord; 2013 Mar; 19(3):397-8. PubMed ID: 22981185
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.
    Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ
    Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematically analyzing rare variants of autosomal-dominant genes for sporadic Parkinson's disease in a Chinese cohort.
    Yang N; Zhao Y; Liu Z; Zhang R; He Y; Zhou Y; Xu Q; Sun Q; Yan X; Guo J; Tang B
    Neurobiol Aging; 2019 Apr; 76():215.e1-215.e7. PubMed ID: 30598256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.
    Jasinska-Myga B; Kachergus J; Vilariño-Güell C; Wider C; Soto-Ortolaza AI; Kefi M; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Yahmed SB; Sassi SB; Zouari M; El Euch G; Ross OA; Hentati F; Farrer MJ
    Mov Disord; 2010 Oct; 25(13):2052-8. PubMed ID: 20721913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease.
    Hedrich K; Winkler S; Hagenah J; Kabakci K; Kasten M; Schwinger E; Volkmann J; Pramstaller PP; Kostic V; Vieregge P; Klein C
    Mov Disord; 2006 Sep; 21(9):1506-10. PubMed ID: 16758483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.
    Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS
    J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Analysis of LRRK1 and LRRK2 Variants in Essential Tremor Patients.
    Chen H; Yuan L; Song Z; Deng X; Yang Z; Gong L; Zi X; Deng H
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):398-402. PubMed ID: 29812962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.